Navigation Links
Teva and Barr Receive FTC Request for Additional Information
Date:9/3/2008

JERUSALEM and MONTVALE, N.J., Sept. 3 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and Barr Pharmaceuticals, Inc. (NYSE: BRL) announced today that, as expected, each party has received a request for additional information (commonly referred to as a "second request") from the U.S. Federal Trade Commission (FTC) in connection with Teva's pending acquisition of Barr. The parties have been cooperating with the FTC staff since shortly after the announcement of the transaction and intend to continue to cooperate with the FTC to obtain HSR clearance as promptly as possible.

The effect of the second request is to extend the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) waiting period until thirty days after the parties have substantially complied with the request, unless that period is terminated sooner by the FTC. The companies continue to expect that the transaction will close in late 2008, following completion of the HSR clearance process, the obtaining of the other required antitrust approvals and the satisfaction of all other closing conditions contained in the merger agreement between the parties, including the approval of Barr stockholders.

About Teva

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The Company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients,
'/>"/>

SOURCE Teva Pharmaceutical Industries Ltd.; Barr Pharmaceuticals,Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. College of American Pathologists' Education Division Receives Top Honor
2. CMS, Inc., an Elekta Company, Receives FDA 510(k) Clearance for Atlas-Based Autosegmentation Software
3. Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
4. UCSF faculty receive $13.7M from CIRM for stem cell research
5. Actavis Receives Approval of Generic Wellbutrin XL(R) 300mg in the U.S.
6. New probe to detect skin cancer receives more funding for clinical trials
7. NUCRYST Receives Deficiency Notice from NASDAQ
8. Dr. Ajrawats Air-Pulse Autonomic Meditation Therapy, a Revolutionary, Scientific, Meditation Therapy, Receives Patent Trademark
9. PathNet Esoteric Laboratory Institute Main Laboratory Receives Accreditation From College of American Pathologists
10. Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis
11. Morris Animal Foundation Receives $1 Million Donation From Hills for Cat Health Research - Cat Lovers Have Reason to Celebrate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... at the University of California, San Diego School of ... who have suffered a recent major loss are more ... adults. , The study is published in this month,s ... . , Because compassionate behaviors are associated with better ... offer insights into ways to improve the outcomes of ...
(Date:4/17/2014)... created a new technology for modifying human cells ... body and selectively target cancer and other sites ... monitor and modify human physiology is a promising ... technology enabled bioengineers to build such devices that ... a customized fashion. , "The project addressed a ...
(Date:4/17/2014)... cause of neuronal death in Parkinson,s disease is still ... be mistaken for foreign invaders and killed by the ... diseases like type I diabetes, celiac disease, and multiple ... April 16, 2014, in Nature Communications . , ... Parkinson,s disease; but if true, it could lead to ...
(Date:4/17/2014)... April 17, 2014 EcoHealth Alliance, a nonprofit organization ... published a comprehensive review today examining the current state ... The review calls for improved global surveillance strategies to ... recent outbreak of Ebola in West Africa that has ... of Guinea and Liberia. According to the World ...
(Date:4/17/2014)... April 2014) Population Council scientists and their partners have ... and can prevent the transmission of multiple sexually transmitted ... animals: HIV, herpes simplex virus 2 (HSV-2), and human ... data that the gel is effective against multiple strains ... the vagina against all three viruses of at least ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... WAA new joint study by Group Health Research Institute ... diabetes patients who received naturopathic care (as an adjunct ... and exercise habits, improved moods, and a stronger sense ... only conventional care. The findings, published today ...
... -- Worrying may have co-evolved with intelligence as an ... For the study, researchers looked at 26 people with ... of 18 healthy volunteers without the disorder. The investigators ... with brain activity measured by the depletion of the ...
... research by an international team of scientists contradict the ... qualities can form invasive tumors. Research led by Ole ... Mina Bissell of the Lawrence Berkeley National Laboratory (Berkeley ... detectable stem cell qualities can generate larger tumors than ...
... "Good fortune favors the well prepared," says Paul ... the Wilderness Medical Society and editor of Wilderness Medicine, ... reading, individuals planning vacations or outdoor excursions can become ... them. "Severe weather, wild animals, rugged ...
... HealthDay Reporter , TUESDAY, April 17 (HealthDay News) -- ... enter the Part D "donut hole," the seniors often ... for heart health, new research shows. "We looked at ... and half months during a year. While we didn,t find ...
... April 18 (HealthDay News) -- Long-term exposure to fine-particle ... hospitalized for lung and heart disease, stroke and diabetes, ... Health researchers compared air-quality data with hospital admission records ... to 3,000 New England hospitals between 2000 and 2006. ...
Cached Medicine News:Health News:Naturopathic care can improve blood sugar, mood in diabetes 2Health News:New findings in breast cancer 2Health News:New findings in breast cancer 3Health News:New findings in breast cancer 4Health News:Wilderness Medicine founder offers health tips for summer season 2Health News:Wilderness Medicine founder offers health tips for summer season 3Health News:Seniors Stop Taking Heart Drugs In Medicare 'Donut Hole' 2Health News:Seniors Stop Taking Heart Drugs In Medicare 'Donut Hole' 3Health News:More Smog Might Mean More Hospitalizations 2
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... Technologies for Advanced Drug Delivery Systems -- ... http://www.reportlinker.com/p01940411/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-End-Users.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology STUDY OBJECTIVES ...
(Date:1/14/2014)... , Jan. 14, 2014 HeartWare International, ... innovator of less invasive, miniaturized circulatory support technologies that ... announced that it expects revenues for the fourth quarter ... full-year 2013 revenues to approximately $208 million. ...
(Date:1/14/2014)... Pa. , Jan. 14, 2014 Dynamic Healthcare Services, ... announced today that it acquired Progressive Home Medical Equipment, Inc. ... 7, 2014. The terms of the acquisition were not disclosed. ... equipment ("DME") company providing a wide range of sleep, mobility, ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... The Albumin Cobalt Binding (ACB®) Test is ... Modified Albumin (IMA®) by measuring the cobalt ... serum sample. First identified in the early ... comes in contact with ischemic tissue in ...
... autoimmune testing feature single-well ANA screen and ... reflex tests including dsDNA, and 6 individual ... (La), Scl-70 and Jo-1. In addition, our ... of products for Cardiolipins (IgA, IgG, IgM), ...
... Professional Diagnostics is a leading provider of ... DFA test menu that includes kits for ... well as miscellaneous conjugates and components. Our ... wide assortment of substrates and kit sizes ...
... provides stability for contact lenses during surgery. ... that are precisely positioned to provide an ... They are constructed from implant grade titanium ... are compatible with all Volk indirect and ...
Medicine Products: